Drug Shortage Report for CLAVULIN 400
Report ID | 110855 |
Drug Identification Number | 02238830 |
Brand name | CLAVULIN 400 |
Common or Proper name | amoxicillin / clavulanate potassium for oral suspension |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | CLAVULANIC ACID AMOXICILLIN |
Strength(s) | 57MG 400MG |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 70mL |
ATC code | J01CR |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-04-01 |
Estimated end date | Unknown |
Actual end date | 2020-06-01 |
Shortage status | Resolved |
Updated date | 2020-06-03 |
Company comments | Re-supply is ongoing with inventory allocated to 100% of regular demand. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2020-06-03 | French | Compare |
v5 | 2020-06-03 | English | Compare |
v4 | 2020-05-01 | French | Compare |
v3 | 2020-05-01 | English | Compare |
v2 | 2020-04-03 | French | Compare |
v1 | 2020-04-03 | English | Compare |
Showing 1 to 6 of 6